Abstract
Esophageal adenocarcinoma is the fastest rising cancer in the United States. It develops from long-standing gastroesophageal reflux disease which affects >20% of the general population. It carries a very poor prognosis with 5-year survival
Original language | English |
---|---|
Pages (from-to) | 841-847 |
Number of pages | 7 |
Journal | Clinical and Translational Science |
Volume | 8 |
Issue number | 6 |
DOIs | |
State | Published - Dec 1 2015 |
All Science Journal Classification (ASJC) codes
- Medicine(all)
- Biochemistry, Genetics and Molecular Biology(all)
- Neuroscience(all)
- Pharmacology, Toxicology and Pharmaceutics(all)